Phone:
+91-2717-430479
Email:
info@arveelabs.com
Link:
https://www1.nseindia.com/emerge/index_sme.htm
Delivering Quality, Thinking Safety, Preserving Nature
Home
About Us
Mission & Vision
Infrastructure
Team
Delivering Quality
Thinking Safety
Preserving Nature
Products
Polymer Modifiers
Dimethyl 5-Sodiosulfoisophthalate
5-Sulfoisophthalic Acid Mono Sodium Salt
5-Sulfoisophthalic Acid Mono Lithium Salt
5-Sodiosulfo-Bis-(β-Hydroxyethyl)-Isophthalate
Contrast Media Intermediates
5-Nitroisophthalic acid
Dimethyl 5-Nitroisophthalate
Monomethyl 5-Nitroisophthalate
5-Hydroxyisophthalic acid
5-Aminoisophthalic acid
Dimethyl 5-Aminoisophthalate
3,5-Dinitrobenzoic Acid
3,5-Diamino Benzoic Acid
Drug Intermediates
2-Acetyl Thiophene
Thiophene-2-Carboxaldehyde
4–Amino Pyridine
2–Chloro–5–Nitrobenzoic Acid
Investor Corner
CODE OF CONDUCT
CORPORATE GOVERNANCE
>
BOARD OF DIRECTORS
COMMITTEES
CORPORATE GOVERNANCE REPORT
ANNUAL SECRETARIAL COMPLIANCE
FINANCIAL INFORMATION
>
ANNUAL RESULTS
QUARTERLY RESULTS
NOTICE FOR ANNUAL GENERAL MEETING
NOTICE FOR BOARD MEETING
INVESTOR GRIEVANCE
SHAREHOLDING PATTERN
ANNOUNCEMENTS
>
ANNUAL GENERAL MEETING
BOARD MEETING
EXTRAORDINARY GENERAL MEETING
VOTING RESULTS & SCRUTINIZER'S REPORT
PROSPECTUS
UPDATES AND NEWS
REGISTRAR AND SHARE TRANSFER AGENT
TRADING WINDOW
RESULTS PUBLICATION
PUBLICATION OF NOTICES GIVEN
TO SHAREHOLDERS
EXTRACT OF ANNUAL RETURN
Research
Career
Contact Us
///
Investor Corner
CODE OF CONDUCT
CORPORATE GOVERNANCE
BOARD OF DIRECTORS
COMMITTEES
CORPORATE GOVERNANCE REPORT
ANNUAL SECRETARIAL COMPLIANCE
FINANCIAL INFORMATION
ANNUAL RESULTS
QUARTERLY RESULTS
NOTICE FOR ANNUAL GENERAL MEETING
NOTICE FOR BOARD MEETING
INVESTOR GRIEVANCE
SHAREHOLDING PATTERN
ANNOUNCEMENTS
ANNUAL GENERAL MEETING
BOARD MEETING
EXTRAORDINARY GENERAL MEETING
VOTING RESULTS & SCRUTINIZER'S REPORT
PROSPECTUS
UPDATES AND NEWS
OTHER UPDATES
CLAUSE 40 DISCLOSURE
CLAUSE 74(5) DISCLOSURE
REGISTRAR AND SHARE TRANSFER AGENT
TRADING WINDOW
RESULTS PUBLICATION
PUBLICATION OF NOTICES GIVEN
TO SHAREHOLDERS
EXTRACT OF ANNUAL RETURN
PROSPECTUS
Demat Audit & Reco of Share Capital Audit 30-06-2022
Consent Letter cum appointment of Statutoty Auditor
Consent Letter of Internal Auditor for FY 22-23
Resignation letter from CA Jaimin Deliwala
Resignation of Independent Director Vishal Mehta
Demat Audit & Reconciliation of Share Capital Audit 31-03-2022
Large Entity Disclosure for 2021-22
Demat Audit & Reconciliation of Share Capital Audit 31-12-2021
Demat Audit & Reconciliation of Share Capital Audit 30-09-2021
LETTER FOR CHANGE IN STATUTORY AUDITOR FROM 1ST JULY 2021
Demat Audit & Reconciliation of Share Capital Audit 30-06-2021
Demat Audit & Reconciliation of Share Capital Audit 31-03-2021
Clause 74(5) Disclosure 31st March 2021
Clause 40 Disclosure 31st March 2021
Large Entity Disclosure
Letter for change in Directors'remuneration
CFO APPOINTMENT
CFO RESIGNATION
Auditors letter for change in Statutory Auditors
Demat Audit & Reconciliation of Share Capital Audit 31-12-2020
Demat Audit & Reconciliation of Share Capital Audit 30-09-2020
Demat Audit & Reconciliation of Share Capital Audit 30-06-2020
Demat Audit & Reconciliation of Share Capital Audit 31-03-2020
Demat Audit & Reconciliation of Share Capital Audit 31-12-2019
Demat Audit & Reconciliation of Share Capital Audit 30-09-2019
Demat Audit & Reconciliation of Share Capital Audit 30-06-2019
Demat Audit & Reconciliation of Share Capital Audit 31-03-2019
Demat Audit & Reconciliation of Share Capital Audit 31-12-2018
Demat Audit & Reconciliation of Share Capital Audit 30-09-2018
Demat Audit & Reconciliation of Share Capital Audit 30-06-2018
Demat Audit & Reconciliation of Share Capital Audit 31-03-2018
Letter for change in Directors' remuneration
Copyright © 2008-2024, Arvee Laboratories (India) Limited. All Rights Reserved.